ArticleSubstance abuse and rehabilitation2017
The opioid overdose epidemic: opportunities for pharmacists.
Article in Substance abuse and rehabilitation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.Addiction (Abingdon, England) · 2021Trial
- Identifying Prescription-Opioid-Related Risks Using Prescription Drug Monitoring Programs' Algorithms and Clinical Screening Tools.Pharmacy (Basel, Switzerland) · 2023Article
- Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain.Pharmacy (Basel, Switzerland) · 2023Article
- Comprehensive Medication Management Services with a Holistic Point of View, a Scoping Review.Pharmacy (Basel, Switzerland) · 2023Article
- Quantifying prescribed high dose opioids in the community and risk of overdose.BMC public health · 2021Article
- "It's way more than just writing a prescription": A qualitative study of preferences for integrated versus non-integrated treatment models among individuals with opioid use disorder.Addiction science & clinical practice · 2021Article
- The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study.Drug and alcohol dependence · 2020Article
- Community Pharmacist Utilization of Legislation That Allows Impact on the Opioid Crisis in the State of Minnesota: A Mixed-Methods Approach.Journal of pharmacy practice · 2020Article
- Preliminary Investigation of Pharmacist-Delivered, Direct-to-Provider Interventions to Reduce Co-Prescribing of Opioids and Benzodiazepines among a Medicare Population.Pharmacy (Basel, Switzerland) · 2020Article
- Communication between pharmacists and primary care physicians in the midst of a U.S. opioid crisis.Research in social & administrative pharmacy : RSAP · 2019Article
- Promising roles for pharmacists in addressing the U.S. opioid crisis.Research in social & administrative pharmacy : RSAP · 2019Article
- Screening tools for detecting problematic opioid use and potential application to community pharmacy practice: a review.Integrated pharmacy research & practice · 2019Article
- Pharmacists' attitudes toward dispensing naloxone and medications for opioid use disorder: A scoping review of the literature.Substance abuse · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.